secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001021771-23-000057
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BRTX prices $2.1M registered direct offering of 685,033 shares at $3.03/share
-----------------------------------------------------------------------------

- Offering of 685,033 shares at $3.03/share for gross proceeds of approximately $2.1M; closing expected July 13, 2023.
- Net proceeds to fund BRTX-100 clinical trials, ThermoStem Program R&D, and general corporate purposes.
- Titan Partners Group acting as sole placement agent with 6% cash fee and up to $60K expense reimbursement.
- Shares offered under effective S-3 shelf registration (File No. 333-269631).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/form8kdtd07112023.htm
  HTML page:      https://secwatch.observer/filing/0001021771-23-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer